Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma by Mai, E K, Bertsch, U, Dürig, J, Kunz, C, Haenel, M, Blau, I W, Munder, M, Jauch, A, Schurich, B, Hielscher, T, Merz, M, Huegle-Doerr, B, Seckinger, A, Hose, D, Hillengass, J, Raab, M S, Neben, K, Lindemann, H-W, Zeis, M, Gerecke, C, Schmidt-Wolf, I G H, Weisel, K, Scheid, C, Salwender, H, Goldschmidt, H

Get full text

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial by Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S, Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo G H, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Get full text

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial by Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S, Schurich, Baerbel, Munder, Markus, Brossart, Peter, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Get full text

Constitutive expression of 8-lipoxygenase in papillomas and clastogenic effects of lipoxygenase-derived arachidonic acid metabolites in keratinocytes by Bürger, Friederike, Krieg, Peter, Kinzig, Andreas, Schurich, Bärbel, Marks, Friedrich, Fürstenberger, Gerhard

Get full text

Phase III trial of bortezomib, cyclophosphamide and dexamethasone in newly diagnosed myeloma by Mai, E.K, Bertsch, U, Durig, J, Kunz, C, Haenel, M, Blau, I.W, Munder, M, Jauch, A, Schurich, B, Hielscher, T, Merz, M, Huegle-Doerr, B, Seckinger, A, Hose, D, Hillengass, J, Raab, M.S, Neben, K, Lindemann, H.-W, Zeis, M, Gerecke, C, Schmidt-Wolf, I.G.H, Weisel, K, Scheid, C, Salwender, H, Goldschmidt, H

Get full text

Molecular analysis of aniridia patients for deletions involving the Wilms' tumor gene by DRECHSLER, M, MEIJERS-HEIJBOER, E. J, ROYER-POKORA, B, SCHNEIDER, S, SCHURICH, B, GROND-GINSBACH, C, TARIVERDIAN, G, KANTNER, G, BLANKENAGEL, A, KAPS, D, SCHROEDER-KURTH, T

Get full text

Tumor induction in initiated mouse skin by phorbol esters and methyl methanesulfonate: correlation between chromosomal damage and conversion (‘stage I of tumor promotion’) in vivo... by Fürstenberger, Gerhard, Schurich, Bärbel, Kaina, Bernd, Petrusevska, Rule T., Fusenig, Norbert E., Marks, Friedrich

Get full text

Rapid and preferential distribution of blood‐borne αCD3εAb to the liver is followed by local stimulation of T cells and natural killer T cells by Wingender, Gerhard, Schumak, Beatrix, Schurich, Anna, Gessner, J. Engelbert, Endl, Elmar, Limmer, Andreas, Knolle, Percy A.

Get full text